Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
Background and Aim: There are limited studies on controlled attenuation parameter (CAP) using Fibroscan XL probe for the diagnosis of hepatic steatosis grade. The aim of this study was to determine whether previously defined optimal cut-offs for CAP using the M probe could be applied for the XL prob...
Main Authors: | Chan, Wah Kheong, Nik Mustapha, Nik Raihan, Mahadeva, Sanjiv, Wong, Vincent Wai-Sun, Cheng, Jenny Yeuk-Ki, Wong, Grace Lai-Hung |
---|---|
Format: | Article |
Published: |
Wiley
2018
|
Subjects: |
Similar Items
-
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
by: Chan, Wah Kheong, et al.
Published: (2017) -
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
by: Kamarajah, Sivesh Kathir, et al.
Published: (2018) -
Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
by: Kamarajah, Sivesh Kathir, et al.
Published: (2019) -
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
by: Wong, Vincent Wai-Sun, et al.
Published: (2019) -
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
by: Shi-En Chong, et al.
Published: (2023-03-01)